Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrrolidine SCHEMBL157612 | 0.97 | — | — | |
| Piperidine SCHEMBL27755341 | 0.94 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2CXCR4MAPTHSD17B10 | |
| Piperidine SCHEMBL476425 | 0.94 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2CXCR4MAPTHSD17B10 | |
| Pyrrolidine SCHEMBL27968527 | 0.94 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2CXCR4MAPTHSD17B10 | |
| Pyrrolidine SCHEMBL14815975 | 0.94 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2CXCR4MAPTHSD17B10 | |
| Piperidine SCHEMBL27925102 | 0.94 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2CXCR4MAPTHSD17B10 | |
| Pyrrolidine SCHEMBL6930404 | 0.94 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2CXCR4MAPTHSD17B10 | |
| Pyrrolidine SCHEMBL14815556 | 0.94 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2CXCR4MAPTHSD17B10 | |
| Piperidine SCHEMBL1396086 | 0.94 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2CXCR4MAPTHSD17B10 | |
| Piperidine SCHEMBL27977836 | 0.92 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2CXCR4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 355 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119677765-A | Method for producing antibiotic macrocyclic peptides | 豪夫迈·罗氏有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119314868-A | Wafer cleaning liquid and semiconductor structure forming method | 中芯国际集成电路制造(上海)有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-119290555-A | Enrichment and detection method for trace mercury ions in water body | 信阳师范大学 | 2025-01-10 | — | — | CN | claimed |
| CN-119297394-A | Lithium battery electrolyte and preparation method and application thereof | 扬州工业职业技术学院 | 2025-01-10 | — | — | CN | claimed |
| CN-119265287-A | Sequencing reaction stabilizer composition and application thereof | 深圳华大生命科学研究院 | 2025-01-07 | — | — | CN | claimed |
| US-20240182421-A1 | SYNTHESIS OF ENDOCHIN-LIKE QUINOLONES | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2024-06-06 | — | — | US | claimed |
| CN-118016514-A | Method for forming semiconductor device and cleaning liquid | 中芯国际集成电路制造(上海)有限公司 | 2024-05-10 | — | — | CN | claimed |
| EP-4308109-A1 | SYNTHESIS OF ENDOCHIN-LIKE QUINOLONES | Oregon Health & Science University (US) | 2024-01-24 | — | — | EP | claimed |
| CN-117042768-A | Synthesis of enodoxine-like quinolones | 俄勒冈健康与科学大学 | 2023-11-10 | — | — | CN | claimed |
| CN-115684144-A | Method for rapidly detecting arsenic content in water | 广东环凯生物技术有限公司 | 2023-02-03 | — | — | CN | claimed |
| US-5723339-A | COMPLEXING WITH AMMONIUM PYRROLIDINE DITHIOCARBAMATE | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1998-03-03 | — | — | US | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0560877-A4 | METHOD AND APPARATUS TO DETOXIFY AQUEOUS BASED HAZARDOUS WASTE | — | 1993-12-29 | — | — | EP | claimed |
| EP-0560877-A1 | METHOD AND APPARATUS TO DETOXIFY AQUEOUS BASED HAZARDOUS WASTE | CLEAN HARBORS, INC. (US) | 1993-09-22 | — | — | EP | claimed |
| US-5221480-A | Concurrent removal of various organics and heavy metals | CLEAN HARBORS, INC. (US) | 1993-06-22 | — | — | US | claimed |
| WO-1992010263-A1 | METHOD AND APPARATUS TO DETOXIFY AQUEOUS BASED HAZARDOUS WASTE | CLEAN HARBORS, INC. (US) | 1992-06-25 | — | — | WO | claimed |
| US-5087370-A | Method and apparatus to detoxify aqueous based hazardous waste | CLEAN HARBORS, INC. (US) | 1992-02-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240182421-A1 | SYNTHESIS OF ENDOCHIN-LIKE QUINOLONES | ENGASE, ESYT2, VPS4B | ALDH1A1 3179/4885SMN1; SMN2 4828/4885CXCR4 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.